NetworkNewsWire Editorial Coverage: Mounting research from
around the world suggests marijuana’s potential to treat multiple
medical conditions ranging from chronic pain to cancer, epilepsy,
HIV/AIDS, anxiety and more. Predicted to reach $55.8 billion by
20251, the global medical marijuana industry presents to
investors a wide array of investment opportunities, driven by
increasing demand for therapeutic applications of the drug. In
turn, funds raised through the public market give marijuana
companies the chance to raise capital to build stronger portfolios,
increase their market reach and revenue, and offer cannabis-based
alternatives to traditional medicine. Companies such as
ChineseInvestors.com, Inc. (CIIX) (Profile:
CIIX), Medical Marijuana, Inc. (MJNA), CV Sciences, Inc.
(CVSI), Terra Tech Corp. (TRTC), and Marijuana
Company of America, Inc. (MCOA) are operating in the
medical marijuana scene and are steadily building a strong
reputation as leading providers of cannabis-based health and
wellness products and services.
Created as a premier source of financial information for
Chinese-speaking investors, ChineseInvestors.com (CIIX) is carving for
itself a hefty portion of the cannabis market through diversified
entry points. Adding to its current operations, CIIX earlier this
week announced (http://nnw.fm/3nlZM) its entry into China’s skincare
industry though the impending launch of a new line of
cannabidiol-based skincare products.
“Although ancient Chinese recognized the medicinal properties of
the cannabis plant, CBD extract appears to be largely unrecognized
in China today for its benefits, including but not limited to, its
potential benefits to the largest visible human organ, the skin.
The effects of increased air pollution on the human body are a
growing concern for many in China. With regard to our skin, toxins
in air pollution promote the production of free radicals, causing
premature aging including coarse wrinkles and dark spots. However,
some dermatologists believe that the anti-oxidants and
anti-inflammatory agents in CBD can potentially have anti-aging
effects on the skin,” the company stated in the press release.
The opportunity here is significant, as you look at the broader
market. China is currently the second largest consumer of skincare
products, generating annual retail sales of more than $29.6
billion2. Research from ReportLinker estimates that
Chinese skincare product retail sales will reach $36.3 billion this
year.
The CBD Magic Hemp Series, to be launched by early September by
CIIX’s wholly-owned CBD Biotechnology Co. Ltd. subsidiary (http://nnw.fm/VC7oZ), will position CIIX as a first
mover in this previously untapped sector of the Chinese skincare
industry. CIIX has filed a record of the product line with the
Chinese Food and Drug Administration, and the company anticipates
capturing “100% of China’s market share in this novel skin care
products category,” since, to its knowledge, other manufacturers
have not yet entered the cannabis skincare product market in
China.
Again targeting an untapped niche of the marijuana market, CIIX
operates the first Chinese-language online store selling
cannabidiol (CBD) products. In December 2016, CIIX launched
www.ChineseCBDoil.com in Shanghai, catering to a
growing audience of Chinese people interested in the benefits of
CBD-based products for the treatment of various medical conditions
such as stress, anxiety, Alzheimer’s disease, and others. In
conjunction with the launch of the website, CIIX introduced the
first Yelp-style social media app in Chinese. The app, approved by
the Apple store, is a platform for reviews and discussions about
cannabis products and provides a comprehensive database of
dispensaries and marijuana strains, all in the Chinese
language.
CIIX is also getting ready to open its first retail store,
primarily targeting the Chinese community in San Gabriel,
California. The store will sell the company’s new OptHemp product
line, launched by subsidiary ChineseHempOil.com, Inc., to treat
pain and inflammation. In July, CIIX announced (http://nnw.fm/6ThNn) that www.ChineseHempOil.com will accept bitcoin payments
for its health products, food and beverages.
Another recognizable marijuana company focused on market firsts
is Medical Marijuana, Inc. (MJNA). MJNA was the
first publicly-traded marijuana company in the United States; the
first to make cannabidiol available domestically and abroad; and
the first to establish a global CBD pipeline that made beneficial
cannabinoid products available to people all over the world. In
addition to establishing an international CBD pipeline, providing
support services to the cannabis industry and working to develop
new markets, MJNA is focusing on the development and distribution
of CBD hemp oil health products such as HempMeds® and Kannaway®, in
addition to developing cannabis medication via subsidiaries AXIM
Biotechnologies, Kannalife™ Sciences, and HempMeds®. The companies
are looking into different delivery methods for marijuana-based
therapies and are targeting a wide range of conditions including
Alzheimer’s, Parkinson’s, epilepsy, multiple sclerosis, cancer,
chronic pain and more.
Medical marijuana player CV Sciences (CVSI)
operates its corner of the market via two different business
segments: pharmaceuticals and consumer products. Its pharmaceutical
division is developing synthetic CBD-based medicines for various
medical conditions, with approval of the U.S. Food and Drug
Administration. Its pipeline currently includes a CBD-based product
designed to support cessation of tobacco addiction. The consumer
products division manufactures and distributes plant-based CBD
products designed to enhance quality of life. CVSI’s flagship
consumer products, PlusCBD Oil and Purified Liquids vaping blends,
are already distributed nationwide via health care providers,
health food stores and online.
Terra Tech (TRTC) is a vertically-integrated
cannabis agriculture company that owns multiple subsidiaries in the
medical marijuana space. One of these subsidiaries is Blüm™, a
retail medical cannabis company that provides medical cannabis as
an alternative treatment for patients with chronic conditions. Also
offering cannabis to the adult-use market in Nevada, where the sale
of marijuana for recreational purposes is legal, Blüm offers
recreational and medicinal consumer products such as flowers and
concentrates produced according to the highest standards of potency
and purity. Terra Tech is committed to cultivating only
high-quality medical marijuana and providing it to qualified and
registered medical marijuana establishments throughout the United
States. At the same time, the company is continuing research to
cultivate and cross-breed medical marijuana strains for the
treatment of many different medical conditions.
As demand for medical marijuana grows, so too does the need for
grow space. Marijuana Company of America (MCOA) is
primarily focused on the marketing and distribution of hemp via a
diverse portfolio of companies, brands, joint ventures and
investments such as hempSMART, Club Harmoneous, GateC Research,
Bougainville and MoneyTrac Technology. The company earlier this
month said it has received financing that it will use to develop a
state-of-the-art 30,000-square-foot greenhouse grow facility in
Oroville, Washington, with joint-venture partner Bougainville
Ventures, Inc. At full capacity, the facility is expected to
accommodate cannabis production and processing of its tenant, a
Tier 3, I-502 licensed grower. MCOA said it plans to replicate this
business model to build its real estate portfolio and increase
revenues.
These public companies, expanding their market reach and brand
recognition in their respective niches of the medical marijuana
market, provide ample opportunities for investors looking for an
entrance into the booming medical marijuana market. Proponents of
marijuana for medical purposes point to a growing number of studies
that confirm the health benefits of cannabis, setting the industry
on track to continue its strong performance and become a key
industry and engine of economic growth.
NNW Editorial Sources:
1. Grand View Research, Inc. (http://nnw.fm/dYk5q)
2. ReportLinker (http://nnw.fm/C9Hw9
For more information on ChineseInvestors.com, please visit:
ChineseInvestors.com (CIIX)
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides to
users (1) access to our news aggregation and syndication servers,
(2) enhanced press release services, and (3) a full array of social
communication solutions. As a multifaceted financial news and
content distribution company with an extensive team of contributing
journalists and writers, NNW is uniquely positioned to best serve
private and public companies that desire to reach a wide audience
of investors, consumers, journalists and the general public. NNW
has an ever-growing distribution network of more than 5,000 key
syndication outlets across the country. By cutting through the
overload of information in today's market, NNW brings its clients
unparalleled visibility, recognition and brand awareness. NNW is
where news, content and information converge.
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
Please see full terms of use and disclaimers on the
NetworkNewsWire website applicable to all content provided by NNW,
wherever published or re-published: http://NNW.fm/Disclaimer
DISCLAIMER: NetworkNewsWire (NNW) is the source of the Article
and content set forth above. References to any issuer other than
the profiled issuer are intended solely to identify industry
participants and do not constitute an endorsement of any issuer and
do not constitute a comparison to the profiled issuer. The
commentary, views and opinions expressed in this release by NNW are
solely those of NNW. Readers of this Article and content agree that
they cannot and will not seek to hold liable NNW for any investment
decisions by their readers or subscribers. NNW are a news
dissemination and financial marketing solutions provider and are
NOT registered broker-dealers/analysts/investment advisers, hold no
investment licenses and may NOT sell, offer to sell or offer to buy
any security.
The Article and content related to the profiled company
represent the personal and subjective views of the Author, and are
subject to change at any time without notice. The information
provided in the Article and the content has been obtained from
sources which the Author believes to be reliable. However, the
Author has not independently verified or otherwise investigated all
such information. None of the Author, NNW, or any of their
respective affiliates, guarantee the accuracy or completeness of
any such information. This Article and content are not, and should
not be regarded as investment advice or as a recommendation
regarding any particular security or course of action; readers are
strongly urged to speak with their own investment advisor and
review all of the profiled issuer's filings made with the
Securities and Exchange Commission before making any investment
decisions and should understand the risks associated with an
investment in the profiled issuer's securities, including, but not
limited to, the complete loss of your investment.
NNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E the Securities Exchange Act of 1934, as amended and
such forward-looking statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. "Forward-looking statements" describe future expectations,
plans, results, or strategies and are generally preceded by words
such as "may", "future", "plan" or "planned", "will" or "should",
"expected," "anticipates", "draft", "eventually" or "projected".
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those projected in the
forward-looking statements, including the risks that actual results
may differ materially from those projected in the forward-looking
statements as a result of various factors, and other risks
identified in a company's annual report on Form 10-K or 10-KSB and
other filings made by such company with the Securities and Exchange
Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this
release are made as of the date hereof and NNW undertake no
obligation to update such statements.
Source:
NetworkNewsWire
Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com